OncoHeart Specialist Care

The nature of cancer diagnosis, treatment and management is evolving rapidly… In recent decades, advancements in oncology have significantly improved patient outcomes, with Australian data showing that 70% of those diagnosed with cancer now survive at least five years after diagnosis, compared to 55% in the 1990s. However, a critical challenge persists -studies suggest that up to 1 in 4 of these survivors will die from cardiovascular disease development within seven years of cancer diagnosis, making it the leading cause of death among cancer survivors. The link between cancer therapies and cardiovascular disease underscores the need for comprehensive care that addresses this unique patient cohort. At OncoHeart Specialist Care, our mission is to bridge this gap by providing specialised cardiology services tailored to the unique needs of cancer patients—before, during, and throughout their survivorship journey. Follow our page to join us in this important journey and stay updated with our efforts to enhance cardiovascular care for cancer patients. We also look forward to sharing educational content and insights on this critical intersection of care. www.oncoheart.com.au

🌟 Meet the OncoHeart Team! 🩺 We are committed to providing dedicated care where heart health 💖 and cancer treatment 🎗️ meet. Our mission 🎯is to address the increased cardiovascular risks and challenges faced by cancer patients and survivors. ❤️ Your health is our top priority, and we are here to support and guide you every step of the way. ✨ See our website for more details about our services. 🌐💻📲 www.oncoheart.com.au #OncoHeart #CardioOncology #HeartHealth #CancerCare #Cardiology #BreastCancer #LungCancer #Leukemia #ProstateCancer #ColorectalCancer #CancerTreatment #Chemotherapy #Immunotherapy #RadiationTherapy #CancerSurvivor #CardiacCare #CardioToxicity #CancerSupport #Oncology #cancernurse #Oncologist #Hematologist #OncoCare #StayTuned #MeetTheTeam

Stay tuned as we bring you insights on how cardiovascular health and cancer care intersect. Together, we can make a difference in both heart and cancer care 💖 #OncoHeart #CardioOncology #HeartHealth #CancerCare #Cardiology #BreastCancer #LungCancer #Leukemia #ProstateCancer #ColorectalCancer #CancerTreatment #Chemotherapy #Immunotherapy #RadiationTherapy #CancerSurvivor #CardiacCare #CancerSupport #Oncology #cancernurse #Oncologist #Hematologist #OncoCare #StayTuned

This growing field of #CardioOncology is focused not just on how #cancertreatments can cause #cardiotoxicity but is mainly centred around keeping hearts safe during cancer treatment so that #canceroutcomes are improved and that #cancersurvivorship is optimised. One in two of us will develop cancer at some point - hence investment in research is critical to be able to fully understand these complex issues. Honoured to have been able to contribute to this JACC Journals manuscript. #Oncology #CardioEd #cancer #prostatecancer #breastcancer #colorectalcancer

Stay connected with us!👩💻👨💻We're now on Facebook and Instagram, sharing updates and information about cardio-oncology! 💖🔗 #CardioOncology #HeartHealth #Cancer #Oncology #Cardiology #CancerTreatment #HeartCare #CancerRecovery #Breastcancer #Prostatecancer #PatientWellness #Cardiotoxicity #CancerSupport #Oncologist #Haemotolgist #Nurse #HeartDiseasePrevention #OncologyCare

#CardioOncology #cardiotoxicity #oncoheart #HeartHealth #CancerCare #Oncology #CardiovascularResearch #oncology #haematology #CancerSurvivorship #HeartDiseasePrevention #CancerTreatment #OncoCardiology #CancerAndHeartHealth #PatientCare #CardiacMonitoring #OncologyResearch #HeartFailure #CardiovascularRisk #breastcancer #prostatecancer #lungcancer #colorectalcancer #Leukemia #Lymphoma #HodgkinsLymphoma #NonHodgkinsLymphoma #MultipleMyeloma #PancreaticCancer #Melanoma #EsophagealCancer #BladderCancer #ThyroidCancer #RenalCancer #CervicalCancer #EndometrialCancer #GastricCancer #TesticularCancer #OvarianCancer #BrainCancer #LiverCancer #SkinCancer

🚨 Uncovering the Cardiovascular Impact of BRAF/MEK Inhibitors: Why Cardio-Oncology Matters 🚨 The advent of BRAF and MEK inhibitors has been a game-changer in the treatment of metastatic melanoma, and their role is expanding to other cancers, including colorectal cancer. With the growing use of these therapies, however, comes a critical concern: cardiovascular adverse events (CVAEs). A systematic review and meta-analysis of 5 randomised controlled trials (RCTs) involving 2,317 melanoma patients sheds light on the significant cardiovascular risks associated with BRAF/MEK inhibitor therapy compared with BRAF monotherapy. Some key findings include: 🔴 Pulmonary Embolism: 4.36x increased risk 🔴 Decreased Left Ventricular Ejection Fraction (LVEF): 3.72x increased risk 🔴 Arterial Hypertension: 1.49x increased risk 🔴 Younger Patients Under 55: 26.5x higher risk of LVEF reduction As cancer therapies evolve, the cardiovascular side effects that come with them must not be overlooked. Cardio-oncology is now a critical part of comprehensive cancer care. Identifying patients who are at higher risk for cardiotoxicity—such as those with certain pre-existing cardiovascular conditions or prior cardiotoxic treatment, is prudent to encourage safer treatment administration. Reference: Mincu, R.I., Mahabadi, A.A., Michel, L., Mrotzek, S.M., Schadendorf, D., Rassaf, T. and Totzeck, M., 2019. Cardiovascular adverse events associated with BRAF and MEK inhibitors: a systematic review and meta-analysis. JAMA network open, 2(8), pp.e198890-e198890. 📌 Disclaimer: This post is for informational purposes only and does not constitute medical advice. Individual treatment decisions should always be made in consultation with qualified healthcare professionals who can evaluate each patient's unique medical needs. Please speak with your healthcare provider for personalised advice. #CardioOncology #CancerCare #HeartHealth #PatientOutcomes #BloodPressure #CancerSurvivorship #OncologyCare #CardiovascularHealth #HeartFailure #CancerTreatment #HealthMonitoring #Cardiology #CardioOncologyCare #LongTermHealth #PreventiveCare #oncoheart #skincancer #BRAF #MEK #LVEF #pulmonaryembolism #hypertension

🚨 Blood Pressure and Cancer: A Match Made in Mortality?🚨 When we think about cancer, blood pressure often doesn’t come to mind. But it should. High blood pressure (hypertension) is more common in cancer patients than in the general population—and research has demonstrated that it's a real risk factor for both heart disease and cancer-related mortality. 🫀🎗️ Studies have shown that high blood pressure is associated with higher cancer-related mortality rates and may increase the risk of certain types of cancer. Moreover, untreated hypertension can complicate cancer treatment by raising the risk of heart failure, particularly with therapies like anthracyclines, ibrutinib, and VEGF inhibitors. This makes early detection and effective management of blood pressure in cancer patients essential. But here’s the crucial point: Hypertension isn’t just a short-term concern. It can develop during cancer treatment—or even years later. Whether it’s adjusting treatment plans, closely monitoring blood pressure or referring patients to a cardiologist, timely intervention can improve health outcomes. ⏱️👨⚕️ 💡 A large, long-term study from the Metabolic Syndrome and Cancer Project, which included over 577,000 participants across Norway, Austria, and Sweden, found that higher blood pressure levels were associated with increased cancer risk and mortality. Interestingly, the relationship between blood pressure and cancer outcomes was stronger in men compared to women. While routine blood pressure management may seem straightforward, in the context of cancer care, it is anything but. Regular monitoring and timely intervention can have a significant impact on both patients during treatment and into their survivorship journey. ✅ 🔍 When was the last time you checked the blood pressure of your cancer patients, or those with a history of cancer? References:  - Askarinejad, A., Alizadehasl, A., Jolfayi, A.G. and Adimi, S., 2023. Hypertension in Cardio-Oncology Clinic: an update on etiology, assessment, and management. Cardio-Oncology, 9(1), p.46. - Stocks, T., Van Hemelrijck, M., Manjer, J., Bjørge, T., Ulmer, H., Hallmans, G., Lindkvist, B., Selmer, R., Nagel, G., Tretli, S. and Concin, H., 2012. Blood pressure and risk of cancer incidence and mortality in the Metabolic Syndrome and Cancer Project. Hypertension, 59(4), pp.802-810. 📌 Disclaimer: This post is for informational purposes only and does not constitute medical advice. Individual treatment decisions should always be made in consultation with qualified healthcare professionals who can evaluate each patient's unique medical needs. Please speak with your healthcare provider for personalised advice. #CardioOncology #Hypertension #CancerCare #HeartHealth #PatientOutcomes #BloodPressure #CancerSurvivorship #OncologyCare #CardiovascularHealth #HeartFailure #CancerTreatment #OncologyNurses #HealthMonitoring #CancerSupport #Cardiology #CardioOncologyCare #LongTermHealth #PreventiveCare #oncoheart

The Surge in Cardio-oncology Interest: Why Now? 📈🫀 Over the past decade, the term "Cardiooncology" has skyrocketed in PubMed searches—and it's no coincidence. As cancer treatments improve, more patients are living longer, but many are facing cardiotoxic effects from those therapies. Are we just catching up to the reality of longer cancer survival and its cardiovascular impact? Is cardio-oncology the potential antedote? What are your thoughts? 👇 OncoHeart Specialist Care #Cardiooncology #CancerCare #CardiovascularHealth #Oncology #Cardiotoxicity #CancerSurvivorship #MedicalResearch #HealthInnovation #LongTermCare #HealthcareTrends #HeartHealth #CancerTreatment #FutureOfMedicine #oncoheart

"To treat or not to treat—that is the question!" 🤔 But is heart disease making that decision for you? ⚡ Interesting study alert! ⚡ It has been reported that between 5% and 43% of cancer patients have pre-existing cardiovascular disease (CVD). However, studies on how CVD impacts treatment regimes and survival are limited. A 2020 study explored how pre-existing CVD affected cancer treatment patterns and survival in lung cancer patients. This large Canadian study of 20,689 patients used statistical models to observe the relationship between CVD and cancer treatment decisions. The median age at diagnosis was 70 and women constituted 49% of the cohort. Approximately half of patients had distant metastases at diagnosis. Here’s a few things they found: 🔹 Lower Treatment Rates: Patients with CVD were less likely to receive surgery (11.2% vs. 18.9%), chemotherapy (16.4% vs. 32.3%) or radiotherapy (26.3% vs. 32.1%). 🔹 Shorter Survival: Overall survival (OS) was significantly lower for those with CVD (5.3 months vs. 9.2 months), as was cancer-specific survival (CSS) (6.0 months vs. 9.8 months). 🔹 Higher Non-Cancer Mortality Risk: CVD increased the risk of non-cancer-related death by nearly 50%, underscoring the need for well-rounded care. 💡 Why does this matter? The authors hypothesised that CVD could have affected treatment options and ultimately patient outcomes—though certainly other factors would be at play (read the full study for details and limitations!). While the study focused on lung cancer, these findings could potentially apply to other cancers as well. 👉 Takeaway: By managing cardiovascular and cancer conditions together, early cardio-oncology engagement has the potential to help patients access a wider range of cancer treatments in a safer manner. Reference: Batra, A., Sheka, D., Kong, S., & Cheung, W.Y., 2020. Impact of pre-existing cardiovascular disease on treatment patterns and survival outcomes in patients with lung cancer. BMC Cancer. 📌 Disclaimer: This post is for informational purposes only and does not constitute medical advice. Individual treatment decisions should always be made in consultation with qualified healthcare professionals who can evaluate each patient's unique medical needs. Please speak with your healthcare provider for personalised advice. #CardioOncology #HeartHealth #CancerCare #OncologyResearch #PatientOutcomes #HealthcareInsights #CancerSurvivorship #LungCancer #PreventiveCardiology #ChronicIllnessCare #IntegratedCare #PatientSafety #HealthcareInnovation #CancerTreatment #MultidisciplinaryCare #PatientFirst #CancerAndHeartDisease #MedicalResearch #StudyInsights #CardioCare #OncologyUpdates #HealthcareEducation #CancerAwareness #HeartAndCancer #oncoheart